Australia Wanda Intl Adds Group Members to Aesthetic Medical Holdings Filing

TL;DR

Australia Wanda Intl updated their 13D filing for Aesthetic Medical, adding Laurena Wu & Wider Huge Group Ltd as members.

AI Summary

Australia Wanda International Company Limited filed Amendment No. 3 to Schedule 13D on December 13, 2024, regarding their holdings in Aesthetic Medical International Holdings Group Limited. The filing indicates a change in the group members, with Laurena Wu and Wider Huge Group Ltd now listed as group members. The specific details of the change in beneficial ownership or the exact percentage held are not detailed in this excerpt.

Why It Matters

This amendment signals a potential shift in control or influence over Aesthetic Medical International Holdings Group Limited, as new group members are disclosed.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D often indicate significant changes in beneficial ownership or control, which can impact stock price and investor strategy.

Key Players & Entities

• Australia Wanda International Company Limited (company) — Filing entity
• Aesthetic Medical International Holdings Group Limited (company) — Subject company
• Laurena Wu (person) — Newly added group member
• Wider Huge Group Ltd (company) — Newly added group member

FAQ

Key Financial Figures

• $0.001 — of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• ea0224764-13da3aust_aesth.htm (SC 13D/A) — 80KB
• ea022476401ex99-h_aesth.htm (EX-99.H) — 6KB
• 0001213900-24-108741.txt ( ) — 87KB

Security and Issuer

Item 1. Security and Issuer. This Amendment No. 3 on Schedule 13D (the “ Amendment ”) is being jointly filed by Australia Wanda International Company Limited, Wider Huge Group Limited and Ms. Laurena Wu (together, the “Reporting Persons”) to amend the Statement on Schedule 13D, initially filed with the Securities and Exchange Commission (the “Commission”) on July 29, 2022 (the “Original 13D”), as amended by Amendment No. 1 to Schedule 13D filed on February 24, 2023 (the “First Amendment”) and Amendment No. 2 to Schedule 13D filed on August 17, 2023 ( together with the Original 13D and the First Amendment, the “Statement”)), with respect to ordinary shares, par value $0.001 per share (“Ordinary Shares”), of Aesthetic Medical International Holdings Group Limited (the “Issuer”). The Statement was jointly filed by the Reporting Persons and MY Universe (HK) Limited, Hainan Oriental Jiechuang Investment Partnership (Limited Partnership), Shenzhen Venture Capital M & A Fund Management (Shenzhen) Co., Ltd., Shenzhen Luohu Red Earth Pioneering Cci Capital Ltd, Shenzhen Capital Group Co., Ltd., Shenzhen Lafang Investment Management Co,.Ltd., and WU Guiqian. The Issuer’s principal executive office is located at 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052. Unless specifically amended hereby, the disclosure set forth in the Statement shall remain unchanged. Capitalized terms used but not otherwise defined in this Amendment shall have the meanings set forth in the Statement.

Purpose of Transaction

Item 4. Purpose of Transaction.

of the Statement is hereby amended by the addition

Item 4 of the Statement is hereby amended by the addition of the following: On December 11, 2024, Australia Wanda International Company Limited acquired 3,313,680 Ordinary Shares and 2,372,110 Ordinary Shares respectively from two other shareholders of the Issuer for nominal consideration pursuant to a settlement agreement.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. Paragraphs (a) – (b) of Item 5 of the Statement are hereby amended to include the following language: (a) (b) The information set forth in the cover pages hereto is hereby incorporated in its entirety herein. Paragraph (c) of Item 5 of the Statement is hereby amended by adding the following: (c) Except as otherwise described herein, no other transactions were effected by the Reporting Persons in the past 60 days.

. Material to be Filed as Exhibits

Item 7 . Material to be Filed as Exhibits.

of the Statement is hereby amended by the addition of the following

Item 7 of the Statement is hereby amended by the addition of the following exhibit: Exhibit No. Description H. Joint Filing Agreement dated as of December 13, 2024 5 SIGNATURE After reasonable inquiry and to the best of my or its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct. Dated: December 13, 2024 Australia Wanda International Company Limited By: /s/ Laurena Wu Name: Laurena Wu Title:   Director Wider Huge Group Limited By: /s/ Laurena Wu Name: Laurena Wu Title:   Director Laurena Wu By: /s/ Laurena Wu 6

View Full Filing

View this SC 13D/A filing on SEC EDGAR